Medisetter Doctor Network

NEW UPDATE ON THE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) On September 25, 2024, Medisetter hosted a landmark sponsored webinar titled New Update on the Treatment of Advanced NSCLC. The event was endorsed by CHEST (American College of Chest Physicians) and K Cancer Hospital, marking a significant milestone by virtue of securing official endorsement by, both, a local and international institution. This endorsement underscored the global relevance and high-quality content of the webinar, aimed at upskilling healthcare professionals in Vietnam in advanced lung cancer treatments. OBJECTIVES: The main objective was to upskill Oncologists and Pulmonologists in treatment of NSCLC, with a particular focus on the use of Vinorelbine oral therapy for treating NSCLC cases in complex patient profiles. The webinar intended to reinforce current global treatment guidelines and to increase awareness about the clinical efficacy and safety of oral chemotherapy in improving survival outcomes in NSCLC patients. SPEAKERS AND KEY HIGHLIGHTS: Chairman: Dr. Do Anh Tu, Vice Director, K Hospital Speakers: Prof. Dr. Silvestri GA from CHEST presented global NSCLC guidelines and clinical trials on Vinorelbine. Dr. Vu Ha Thanh from K Hospital discussed persistent treatment gaps in Vietnam’s NSCLC care, showcasing a successful case study of Vinorelbine’s use. Both speakers highlighted the significant role of Vinorelbine, particularly in improving treatment outcomes and managing side effects, reinforcing the importance of making this oral therapy more accessible within Vietnam. Audience Engagement and Feedback: The webinar attracted 184 attendees, mainly Oncologists, Pulmonologists and Respiratory specialists, achieving a high engagement rate: Show-up rate: 56% Average attendance duration: nearly 50 minutes, demonstrating strong interest and relevance.   IMPACT: The webinar set a new benchmark in Vietnam’s medical education landscape by securing the endorsement of the prestigious American College of Chest Physicians (CHEST). The high level of audience engagement demonstrated a clear interest in the latest advancements in NSCLC treatment and the practical applications of oral chemotherapy. The interactive sessions fostered in-depth discussions on Vinorelbine’s role in NSCLC management, especially for patients with complex comorbidities like renal and hepatic impairment.

To commemorate World Palliative Care Day (WHPCD) 2024, Medisetter, in collaboration with Y Học Cộng Đồng and Hospice Spring, hosted an insightful and impactful webinar on October 12, 2024. The theme was “10 Years Since the Resolution: What Have We Done?”, marking a decade since the World Health Assembly resolution on strengthening palliative care services globally. This year's theme encouraged reflection and renewed action toward enhancing palliative care at every level of society. The event featured a diverse panel of international and domestic healthcare professionals, with discussions focused on the pressing need to improve #palliative care access, collaboration, and the integration of care across different sectors. The event also spotlighted key global and local achievements and ongoing challenges in palliative care. Key Highlights: Total registrations: 359 Total attendees: 196 Show-up rate: 54.6% Presenters: - WHO Essential Palliative Care Package: Prof. Eric L. Krakauer, Harvard University, shared insights on the need for comprehensive palliative care in Vietnam and introduced the WHO essential palliative care package. 10-Year Review: Dr. Stephen Connor, Executive Director - Worldwide Hospice Palliative Care Alliance, provided a detailed report on the progress made since the 2014 World Health Assembly resolution. Building Capacity in Asia: Mr. Giam Cheong Leong, Executive Director of APHN, presented on the regional efforts to build palliative care capacity, highlighting the challenges and successes in the Asia-Pacific region. Challenges in Pain Management: Dr. Nguyễn Nam Bình from FV Hospital discussed the difficulties in implementing pain relief methods in Vietnam. Inpatient Palliative Care: Dr. Lê Công Định, Deputy Head of the Palliative Care Department at Hanoi Oncology Hospital, shared challenges in inpatient palliative care within Oncology hospitals. Community Hospice Access: Dr. Võ Thành Long, Executive Director of Hospice Spring, outlined the hurdles in providing community-based palliative care. Patient & Family Support: Dr. Phạm Nguyên Quý, from Kyoto Miniren Hospital, emphasized the importance of guiding patients and families towards early adoption of palliative care services. Outcome and Impact: The webinar catalyzed a rich discussion around the importance of expanding palliative care services in Vietnam, with nearly 200 virtual attendees, including healthcare professionals and policymakers. The audience actively participated in a Q&A session, raising important concerns and sharing their experiences. This event successfully raised awareness about the critical need for palliative care and will potentially foster further collaboration among key stakeholders. The event’s success reflects Medisetter’s commitment to facilitating knowledge exchange and bridging Vietnam’s healthcare system with global centers-of-excellence and bringing international best practices in clinical care to Vietnam and other developing countries..

The Power of Authenticity in Advertising to Physicians: An Interactive Webinar featuring Dr. Joshua Landy! Tired of marketing messages that miss the mark with physicians? Join us for a complimentary webinar on November 12th where Dr. Joshua Landy, MD, dives deep into the power of authenticity in pharmaceutical advertising. In this session, you'll learn: - Why traditional marketing approaches often fall short when reaching physicians - How fostering a culture of empathy within your team can revolutionize your content - Strategies to create authentic messages that resonate with busy medical professionals - How to set a new standard for impactful pharmaceutical communications This webinar is perfect for: - Digital Marketers - Omnichannel Marketing Specialists - Communications Professionals - Brand and Product Managers - Clinical Educators Date & Time: November 12th, 2024 6:00 PM - 7:00 PM (ICT) About Dr. Joshua Landy: Dr. Landy is a recognized expert in the field of pharmaceutical marketing and a Co-Founder and erstwhile Chief Medical Officer of the leading physician network Figure 1 which was acquired by Physician’s Weekly (PW), a leading healthcare content provider, in February 2024. Don't miss this opportunity to gain valuable insights from a physician and highly successful digital healthcare innovator! Register Now: https://lnkd.in/gcMJXDGa Space is limited, so register today!

WORLD MENTAL HEALTH DAY 2024 COMMEMORATION OVERVIEW To commemorate World Mental Health Day 2024, Medisetter played a pivotal role in digitally promoting and hosting two key livestreamed virtual events, aligning with the global theme “Mental Health in the Workplace.” Both events gathered healthcare professionals (HCPs), researchers, and leaders to discuss mental health challenges in the workplace and provided actionable insights for the healthcare community. Event 1: Mental Health of HCPs in Vietnam (Oct 9, 2024 | 19:00 - 22:00) Collaborating Organization: Vietnam Psychiatric Association (VNPA) Key Participants: • Representatives from WHO Vietnam • Ministry of Health (MOH) Highlights: - Total registration: 330 - Total attendees: 239 - Show-up rate: 72.4% This event brought to light the growing mental health challenges faced by healthcare professionals (HCPs) in Vietnam. Various stakeholders shared current research findings, discussed the impact of workplace stress on mental health, and outlined potential initiatives and plans for 2025. The session emphasized the importance of addressing mental well-being in healthcare settings, where the stakes for stress and burnout are higher. The collaborative nature of the discussion and the in-depth presentation of the data provided a solid framework for future mental health interventions among HCPs in Vietnam. Event 2: Psychological First Aid and Mental Health Interventions (Oct 10, 2024 | 19:30 - 21:30) Collaborating Organization: Oxford University Clinical Research Unit (OUCRU) Key Participants: • VNPA Representatives • Infectious Disease Hospital Highlights: - Total registration: 291 - Total attendees: 247 - Show-up rate: 84.9% On October 10, the focus shifted to providing psychological support and mental health care to healthcare workers. Representatives from OUCRU, VNPA, and the Infectious Disease Hospital presented valuable insights on psychological first aid for healthcare staff and researchers, focusing on practical workplace mental health interventions. Additionally, real-world case studies and mental health care activities at the Infectious Disease Hospital were shared, offering participants guidance on implementing mental health practices in their respective workplaces. IMPACT These events showcased Medisetter’s commitment to enhancing the holistic professional and personal development of healthcare professionals in Vietnam, including providing mental health support. The inclusion of expert speakers, reputed institutional partners, research-backed discussions, and the ability to connect digitally with a broad nationwide audience created an invaluable platform for collaboration and learning.

Medisetter Hosts a Successful Webinar on "Management of Pain in Musculoskeletal Disorders: Clinical Case Studies" On August 29th, 2024, Medisetter successfully hosted a webinar on the topic of Pain Management in Musculoskeletal Disorders, focusing on Clinical Case Studies. The webinar, designed to provide actionable insights for healthcare professionals (HCPs), particularly Rheumatologists, Orthopedic Surgeons, Pain Specialists, and General Practitioners, Internal Medicine Doctors was led by Specialist II Dr. Châu Trần Phương Tuyến from Chợ Rẫy Hospital. 🔧 Our Scope of Work: Webinar Organization & Execution: Medisetter managed the entire content development, speaker recruitment, and technical execution processes. Promotion and Participant Recruitment: We promoted the webinar to over 50,000 HCPs across multiple digital platforms, including specific targeting initiatives aimed at 6,022 HCPs in the most relevant specialties in our network. Post-Webinar Access / Reinforcement: We provided access to a recorded version of the webinar on our app, allowing attendees to revisit the content while also making the content accessible to those who were interested in the topic but were unable to attend the event. 📊 Outcome: The webinar realized a total of 362 unique registrations, with a healthy attendance rate of 45%, leading to 162 total participants. The average attendance time was equivalent to an impressive 75% of the total webinar duration, and the discussions on clinical case studies were well received with several questions received from the audience. Refer to comments section below for more details. #Medisetter #continuingmedicaleducation #pain #musculoskeletal #arthritis #pain #chronicpain #sportsmedicine #orthopedic #boneandjoint #rheumatology

On August 9th, 2024 Medisetter hosted a pivotal virtual CME event (4 points) to provide a review of the latest scientific and clinical literature on stroke risk factors, based on the latest evidence. This event was designed for HCPs seeking to not only enhance but also expand their knowledge and practice in stroke and with a particular relevance to Cardiologists, Endocrinologists, Internists and General Practitioners Medisetter was honored to collaborate with the University of Health Sciences – Vietnam National University, Ho Chi Minh City on this event. Future directions for stroke care in Vietnam include the development of national guidelines for stroke diagnosis and treatment in the local language. The event was attended by 308 HCPs , who clocked an average attendance duration of over 1.5 hours. Significantly, out of a total of 118 attendees who took the in-event feedback survey, 117 respondents rated the topic 4 points or above on a scale of 1 to 5 while 115 respondents rated the speaker presentations 4 points or above. Last but not least, we were pleasantly surprised to receive an enthusiastic response to our newly launched post event, self-paced CME facility with a significant number of registrations on our online training platform being realized within the first few days after the event. #eCME #CME #Continuingmedicaleducation #Stroke #Cardiovascular #Vietnammedical #Stroke Learn more at the event at the link below: https://lnkd.in/gZaTni8c

CASE STUDY: HYBRID EVENT SUPPORT: CONQUERING ENDOCRINE DIABETES - NOT A SOLO JOURNEY OVERVIEW: In the last week of July 2024, Medisetter coordinated with a reputed distributor in medical instruments, diagnostics, and lab equipment to provide an end-to-end digital solution for a comprehensive clinical education session on updates in diagnosis of Endocrinological Diseases, specifically Hyperparathyroidism, Hyperaldosteronism and, most importantly, Diabetes. This hybrid event aimed to shed light on effective management strategies for Diabetes in particular and Endocrinological diseases in general, while fostering a sense of community and collaboration among healthcare professionals. OUR SCOPE OF WORK: Medisetter delivered an end-to-end solution, which included: Distribution of Invitations:  We distributed the event information to its member HCPs using a targeted multichannel approach; Webinar Planning and Organization: We coordinated all digital aspects of the hybrid conference to ensure seamless execution and livestreaming across multiple digital touchpoints; Offline CSR Initiatives: We helped the sponsor deliver on its plans to support 100 disadvantaged children by providing each with a decorative study tool set and handwritten greetings. Post-event report and analysis: We provided summary statistics on content distribution, participant recruitment and in-event engagement. The content direction was provided by the sponsor to align with their objectives and messaging. OUTCOME:   Virtual Audience: 184 attendees comprising clinicians (Endocrinologists, Internists and Others), Lab technicians and other HCPs with a peak attendee count of 158. Attendance Rate: 82% of registered attendees participated in the event. Average Duration of Attendance: 74% of Total webinar duration. Successful CSR Activities: Over 100 healthcare professionals who were attending the event offline joined hands to support a gift-wrapping activity for underprivileged children heading to school. This segment of the conference highlighted Medisetter's commitment to both professional education and community support. The high level of engagement and positive feedback underscores Medisetter's effectiveness in delivering impactful hybrid conferences that blend educational excellence with community involvement.

The drug trastuzumab deruxtecan (Enhertu) can now be used to treat a wide variety of cancers, thanks to a new approval from the Food and Drug Administration (FDA). On August 5, the agency gave an accelerated approval for trastuzumab deruxtecan—often called T-DXd—to treat anyone with any advanced solid cancer if their tumors produce high levels of the protein HER2, or HER2-positive. To receive the drug, a patient must already have received at least one prior treatment. The approval makes T-DXd the first cancer therapy of its type, an antibody─drug conjugate, that can be used in such a “tumor agnostic” manner. T-DXd is already approved to treat people with several specific cancers, including breast and stomach. #oncology #cancer https://lnkd.in/gtYmVXyC

While the pharmaceutical industry has fully grasped the potential of digital channels for future HCP engagement, the industry is yet to get the formula right. Here, we identify some of the key problems with prevailing pharmaceutical digital marketing practices and propose possible solutions to help the industry unlock the full power of digital channels for HCP engagement. #digital #pharma #continuingmedicaleducation #edetailing #HCPengagement #doctornetwork

Elevated amounts of the sugar alcohol xylitol are associated with heightened incident risk of major adverse cardiovascular events (MACE) and enhanced platelet reactivity and thrombosis potential, according to new research from Cleveland Clinic with significant public health implications.. https://lnkd.in/gM6ws5Ex